Bacitracin EP Impurity B
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

149146-35-0Bacitracin EP Impurity B

● In Stock

Catalogue No.:VE0026802
CAS No.:149146-35-0
Mol. Formula:C64H99N17O16S
Mol. Weight:1394.66 g/mol

Additional information on CAS 149146-35-0

Parent drug

Bacitracin

IUPAC Name

4,10-anhydro[N-[[(4R)-2-[(1S)-1-amino-2-methylpropyl]-4,5-dihydro-1,3-thiazol-4-yl]carbonyl]-L-leucyl-D-α-glutamyl-L-valyl-L-lysyl-D-ornithyl-L-isoleucyl-D-phenylalanyl-L-histidyl-D-α-aspartyl-L-asparagine]

Pharmacopeial Synonyms

Bacitracin D2; Bacitracin C3

Synonyms

N/A

Description

Bacitracin EP Impurity B, also designated Bacitracin D2 or Bacitracin C3, is a closely related bacitracin peptide variant recorded under CAS 149146-35-0. With molecular formula C64H99N17O16S and molecular weight 1394.66 g/mol, it belongs to the cyclic dodecapeptide antibiotic impurity profile arising from biosynthetic microheterogeneity, enzymatic processing variants, or minor degradation during fermentation and isolation. Its structural similarity to bacitracin A complicates chromatographic resolution, often requiring high-resolution reversed-phase LC coupled to UV, LC-MS/MS, and, where structural confirmation is needed, high-resolution mass spectrometry and tandem fragmentation analysis. Regulatory characterization is relevant for impurity mapping and compositional control in peptide-derived drug substances.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url